Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![FirstSquawk Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::3295423333.png) First Squawk [@FirstSquawk](/creator/twitter/FirstSquawk) on x 384.9K followers
Created: 2025-07-17 11:02:06 UTC

Bristol Myers Squibb and Pfizer launched a direct-to-patient option for ELIQUIS® (apixaban) and expanded the ELIQUIS XXX support program, giving cash-paying patients over XX% off the current price.


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945801178425741491/c:line.svg)

**Related Topics**
[$bmy](/topic/$bmy)
[stocks healthcare](/topic/stocks-healthcare)
[$pfe](/topic/$pfe)

[Post Link](https://x.com/FirstSquawk/status/1945801178425741491)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

FirstSquawk Avatar First Squawk @FirstSquawk on x 384.9K followers Created: 2025-07-17 11:02:06 UTC

Bristol Myers Squibb and Pfizer launched a direct-to-patient option for ELIQUIS® (apixaban) and expanded the ELIQUIS XXX support program, giving cash-paying patients over XX% off the current price.

XXXXX engagements

Engagements Line Chart

Related Topics $bmy stocks healthcare $pfe

Post Link

post/tweet::1945801178425741491
/post/tweet::1945801178425741491